Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplant

Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplant

Item
http://www.wikidata.org/entity/Q34088370
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.How I treat FLT3-mutated AML.Life after transplant: are we becoming high maintenance in AML?Pharmacologic maintenance strategies following allogeneic hematopoietic cell transplantation for acute myeloid leukemia.The role of FLT3 inhibitors in the treatment of FLT3-mutated acute myeloid leukemia.Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission.High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation.The Successful Complete Remission Induction by Sorafenib Monotherapy in a FLT3-D835Y-Positive Patient with Refractory Acute Monocytic Leukemia.Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 Relationship.
P2860

Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplant

Item
http://www.wikidata.org/entity/Q34088370
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sorafenib is tolerable and imp ...... after relapse post-transplant
@ast
Sorafenib is tolerable and imp ...... after relapse post-transplant
@en
Sorafenib is tolerable and imp ...... after relapse post-transplant
@nl
type
label
Sorafenib is tolerable and imp ...... after relapse post-transplant
@ast
Sorafenib is tolerable and imp ...... after relapse post-transplant
@en
Sorafenib is tolerable and imp ...... after relapse post-transplant
@nl
prefLabel
Sorafenib is tolerable and imp ...... after relapse post-transplant
@ast
Sorafenib is tolerable and imp ...... after relapse post-transplant
@en
Sorafenib is tolerable and imp ...... after relapse post-transplant
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Sorafenib is tolerable and imp ...... after relapse post-transplant
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932